Stock Taper
TECH
BIO-TECHNE CORPORATION
NASDAQ
$72.35
▼ DOWN 0.17% (-0.12)

KEY STATISTICS

Market Cap$11.33 B
52w High$72.62
52w Low$43.20
Dividend Yield0.55%
FrequencyIrregular
P/E37.29
Volume1.63M
Shares Out.156.57M

COMPANY

LEADERSHIP

Kim Kelderman
CHIEF EXECUTIVE
Kim Kelderman

COMPENSATION 2026

Salary$936,000
Stock Awards$3,929,942
Incentive Plan Pay$1,318,917
All Other Comp.$33,473
Total$8,151,181

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 9, 1989
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
3,000

PRICE TARGET

Target High$73.00
Target Low$50.00
Target Median$73.00
Target Consensus$65.78

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$292.06M
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
2022-11-30Forward4:1
2000-12-04Forward2:1
1997-11-18Forward2:1

PRICE

$72.35 ▼ DOWN 0.17% (−$0.12)
OVERLAYS
$72.36$72.40$72.449:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM72.35

About Bio-Techne Corporation

https://www.bio-techne.com ↗

Bio-Techne develops and sells life science reagents, instruments, and diagnostic products worldwide through its Protein Sciences and Diagnostics & Genomics segments.

INDUSTRY

Biotechnology

A PRODUCT BIO-TECHNE CORPORATION IS KNOWN FOR

Ella Automated Immunoassay System
Ella Automated Immunoassay System

The Ella is a CE-IVD-marked, automated benchtop immunoassay platform using microfluidics to deliver rapid, multiplex biomarker detection (up to 8 analytes in under 90 minutes), minimizing manual steps for clinical diagnostics.

Revenue by Products

IconPRODUCTQ1-2026Q2-2026Q3-2026Q4-2026
Consumables$231.6M $235.44M $257.34M $260.73M
Instruments$21.83M $29.61M $27.66M $31.54M
Royalty$5.65M $8.51M $4.97M $5.87M

Revenue by Geography

MapREGIONQ1-2026Q2-2026Q3-2026Q4-2026
U S$155.24M $146.56M $167.48M $166.1M
Europe$65.13M $75.35M $73.45M $80.29M
C N$24.79M $26.35M $26.01M $26.91M
APAC excluding Greater China$19.15M $22.74M $21.82M $22.11M
UNITED KINGDOM$13.21M $13.73M $14.89M $14.46M
Rest Of World$9.05M $11.14M $7.77M $11.32M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity4
Return On Assets4
Debt To Equity3
Price To Earnings1
Price To Book2
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
April Delaney
April Delaney
Sale
2026-04-08
Rob Bresnahan
Rob Bresnahan
Sale (Full)
2025-04-08
Julie Johnson
Julie Johnson
Sale
2025-04-01
Ro Khanna
Ro Khanna
Sale
2023-11-03

INSIDER TRADES

OFFICER: SVP - GENERAL COUNSEL
Bohnen Shane
Purchase · 18.4K shares
2026-08-17
OFFICER: PRESIDENT - DIAG & SPATIAL BI
Crouse Steven C.
Purchase · 8.7K shares
2026-08-17
OFFICER: SVP - GENERAL COUNSEL
Bohnen Shane
Purchase · 11.3K shares
2026-08-17
OFFICER: CFO
Hippel James
Purchase · 22.4K shares
2026-08-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 3
EQUAL WEIGHT 2
NEUTRAL 2
BUY 2
SECTOR PERFORM 1
MARKET PERFORM 1
IN LINE 1
12 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
MRNA$137.99COMPARE
RVMD$207.88COMPARE
JAZZ$244.54COMPARE
EXEL$54.45COMPARE
BMRN$64.67COMPARE
MDGL$533.76COMPARE
CORT$113.88COMPARE
QGEN$43.11COMPARE